Hilltop Holdings’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,081
Closed -$206K 449
2019
Q3
$206K Buy
+2,081
New +$198K 0.04% 372
2018
Q4
Sell
-4,265
Closed -$382K 447
2018
Q3
$382K Sell
4,265
-507
-11% -$44.8K 0.08% 277
2018
Q2
$379K Sell
4,772
-1,743
-27% -$145K 0.08% 263
2018
Q1
$581K Buy
6,515
+13
+0.2% +$1.25K 0.1% 207
2017
Q4
$678K Buy
6,502
+1,704
+36% +$192K 0.15% 163
2017
Q3
$699K Sell
4,798
-1,049
-18% -$143K 0.21% 121
2017
Q2
$759K Buy
5,847
+89
+2% +$10.9K 0.22% 133
2017
Q1
$717K Sell
5,758
-55
-0.9% -$6.58K 0.22% 138
2016
Q4
$672K Sell
5,813
-140
-2% -$15.6K 0.21% 146
2016
Q3
$622K Buy
5,953
+57
+1% +$6.17K 0.2% 158
2016
Q2
$582K Sell
5,896
-233
-4% -$24.1K 0.19% 159
2016
Q1
$614K Buy
6,129
+1,427
+30% +$147K 0.19% 157
2015
Q4
$563K Buy
4,702
+414
+10% +$47.9K 0.16% 172
2015
Q3
$464K Buy
+4,288
New +$532K 0.14% 195
2015
Q2
Sell
-3,063
Closed -$353K 368
2015
Q1
$353K Buy
+3,063
New +$366K 0.09% 245
2014
Q3
Sell
-3,682
Closed -$316K 235
2014
Q2
$316K Buy
3,682
+94
+3% +$7.15K 0.15% 166
2014
Q1
$250K Buy
3,588
+20
+0.6% +$1.58K 0.12% 186
2013
Q4
$301K Sell
3,568
-56
-2% -$4.43K 0.15% 161
2013
Q3
$279K Buy
3,624
+84
+2% +$5.89K 0.16% 150
2013
Q2
$207K Buy
+3,540
New +$213K 0.14% 161

Other funds holding CELG

Hilltop Holdings's CELG Position: Q4 2019 in Review

Hilltop Holdings sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,081 shares — an estimated $206K sold.

Hilltop Holdings first reported a position in CELG in Q2 2013 and held it in 20 quarters. The position peaked at $759K in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Hilltop Holdings reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Hilltop Holdings sold 2,081 Celgene Corp shares in Q4 2019, an estimated $206K.
  • Hilltop Holdings first reported a position in Celgene Corp in Q2 2013 and held it in 20 quarters.
  • Hilltop Holdings's Celgene Corp position peaked at $759K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hilltop Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.